Moderna
Facts
26 propertiesIdentity
- Instance of
- business, public company, biopharmaceutical company[4][5]
- Official website
- www.modernatx.com[16]
- Legal form
- Delaware corporation[29]
- Official name
- Moderna, Inc.[28]
Status and dates
Location
- Country
- United States[3]
- Located in the administrative territorial entity
- Cambridge[2]as of 2026-10-21
where from?
- Record
- ror.org/01xm4wg91
- Edition
- 20261021 · as of 2026-10-21
- Bronze
7a7bf58d5ac18436v2.15-2026-10-20-ror-data.zip- Transform
- 4ort-mint · ror:20261021 · version not recorded
Industry and activity
- Field of work
- RNA vaccine[1]
- Product or material produced
- medication[18]
Financials
- Operating income
- 9.4B (-763.0M–13.3B, n=7)
People
- Chief executive officer
- Stéphane Bancel (2011–present)[10]
- Board member
- Stéphane Bancel (2011–present), Tal Zaks (2015–present), Noubar Afeyan (2012–present), Robert S. Langer, Jr. (2010–present), Elizabeth Nabel (2015–present), Israel Ruiz (2017–present), Paul Sagan (2018–present), Moncef Slaoui (2017–present)[57][58][59][60][61]
- Director / manager
- Stéphane Bancel[17]
Relations
- Owned by
- Noubar Afeyan (2020), Stéphane Bancel (2020), Robert S. Langer, Jr. (2020)[6][7][8]
- ROR ID
- 01xm4wg91
- ISNI
- 0000000417913172
- Legal Entity Identifier
- 549300EI6OKH5K5Q2G38
- GRID ID
- grid.479574.c
- Image (Wikimedia Commons)
- Moderna Headquarters, December 2020.jpg ↗
- Article ID in the Lithuanian Universal Encyclopedia Online
- moderna
- BBC News topic ID
- c8grzynv1mgt
- BBC Things ID
- 2b59e04a-9f5d-4ee4-a733-079d62f06f2d
- Bloomberg company ID
- MRNA:US
- Central Index Key
- 0001682852
- Crunchbase organization ID
- moderna-therapeutics
- Delaware Division of Corporations file number
- 6104873
Show all 31 identifiers +19
- Described at URL
- apnews.com
- EU Transparency Register ID
- 011080341579-06
- Facebook username
- modernatx
- Freebase ID
- /m/0w2ztxm
- Golden ID (archived)
- Moderna_Therapeutics-EY4K96
- HAND ID
- 5BEF-4E09-A110-45E5-4525
- IRS Employer Identification Number
- 81-3467528
- ISIN
- US60770K1079
- Lex ID
- Moderna_Inc.
- Open Funder Registry funder ID
- 100019533as of 2026-10-21
where from?
- Record
- ror.org/01xm4wg91
- Edition
- 20261021 · as of 2026-10-21
- Bronze
7a7bf58d5ac18436v2.15-2026-10-20-ror-data.zip- Transform
- 4ort-mint · ror:20261021 · version not recorded
- OpenCorporates organization ID
- us_de/6104873
- Press information URL
- www.modernatx.com
- Quora topic ID
- Moderna-Therapeutics
- Ringgold ID
- 380888
- Scilit organization ID
- 69783
- UK Parliament thesaurus ID
- 479919
- WikiKids ID
- Moderna
- X (Twitter) username
- moderna_tx (2013–present)
- YouTube channel ID
- UChCzhLMQnwF1w-_J8q1IpPA (2011–present)
- ROR (Research Organization Registry)
- OpenAlex CC0 1.0 (OpenAlex snapshot, openalex.org). Values as shipped.
From open datasets, joined by identifier and shown only for properties Wikidata does not state on this entity — except where the dataset is the registry authority for the fact (ClinicalTrials.gov on trial registration data): there its value is shown instead, with Wikidata's noted beside it. Every row carries its dataset edition and licence.
Board member 4
Owns / has subsidiaries 4
Employees / affiliates 3
Owned by 3
Industry 2
Instance of 2
← Ultimate parent organization 2
Chief executive officer 1
Country 1
Director / manager 1
Field of work 1
Headquarters location 1
Legal form 1
Product or material produced 1
Stock exchange 1
← Affiliation 1
← Developer 1
← Manufacturer 1
0 sources
Financials
0001682852-26-000033high ≥ 0.90 · emerging ≥ 0.65 · low below — calibrated against hand-rated truth (single-source .44 · two-source .62 · production-typical .70), so a band is a measurement, not a promise. High is rare by design: it needs both a supported assertion and an evidence sentence. A confirmed or contradicted chip is a Wikidata cross-check; no chip means Wikidata has no value for that property — the ordinary case here, and it says nothing either way. A confirm-only note marks a property whose check can never disagree (Wikidata's border and capital data is not exhaustive), so silence there is a limit of the check, not of the claim.
evidence “Developments in tackling cancer—such as the encouraging results of an mRNA cancer vaccine that were announced by Moderna and Merck last month—stem from “decades of progress, decades of new knowledge, decades of even failure, and learning from that failure to bring forth these kinds of results,” Jacobson said.” time.com · read source
evidence “Moderna's vaccine is approved for ages six months and older, while Pfizer's shot can be given to people over the age of five.” dailymail.com · read source
evidence “It was Moderna's (NASDAQ:” aol.com · read source
evidence “BioNTech and Moderna may have bright futures as they advance their vaccine candidates.” fool.com · read source
evidence “The information we have on clinical trial results comes courtesy of pharmaceutical companies Moderna and Merck and hasn’t been officially published yet.” womenshealthmag.com · read source
evidence “Moderna is still an unprofitable biotech burning cash, with FY 2025 revenue of $1.94 billion, down 40% year over year, and 2026 guidance calling for year-end cash of $4.7 billion to $5.2 billion, down from $8.1 billion.” finance.yahoo.com · 2026-09-16 · read source
evidence “Moderna (MRNA) lit up the biotechnology sector at a pace not seen since the COVID pandemic.” baystreet.ca · read source
evidence “Second, while by all means a likely game changer for Moderna, commercialization of these oncology MRNA products remains years away.” fool.com · read source
evidence “Moderna led the S&P 500 in August after reporting promising results from a late-stage trial of a personalized mRNA cancer vaccine it co-developed with Merck, according to CNBC.” finance.yahoo.com · read source
evidence “Now working at pharmaceutical company Moderna in Cambridge, Massachusetts, she uses AI to improve manufacturing processes by working out the most promising parameters of an experiment and identifying areas for further investigation.” nature.com · read source
evidence “The basis of Moderna, Inc.’s (NASDAQ:MRNA) recent transition is its co-development partnership with Merck.” insidermonkey.com · read source
evidence “Drugmakers Moderna and Merck this summer announced that a cancer vaccine, intismeran autogene, had succeeded in a Phase 3 clinical trial in preventing the recurrence of melanoma, a result experts celebrated as a breakthrough for mRNA-based cancer treatments.” spokesman.com · read source
evidence “The information we have on clinical trial results comes courtesy of pharmaceutical companies Moderna and Merck and hasn’t been officially published yet.” womenshealthmag.com · read source
evidence “Moderna faces intense competition in the vaccine and oncology sectors from established giants like Pfizer (PFE -0.43%), GSK (GSK -1.85%), and Sanofi (SNY -1.58%).” fool.com · read source
evidence “Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III” aol.com · read source
evidence “Were you specifically thinking of this Merck-Moderna trial?” news.harvard.edu · read source
Show 3 low-confidence claims
Published, not hidden — scoring low is not a reason to withhold a sourced claim. A contradicted chip means Wikidata holds a different value; both are shown so you can judge.
evidence ““You have many, many more shots on goal and therefore a much greater chance to succeed,” Moderna co-founder and MIT scientist Robert Langer said via email.” arynews.tv · read source
evidence “Now working at pharmaceutical company Moderna in Cambridge, Massachusetts, she uses AI to improve manufacturing processes by working out the most promising parameters of an experiment and identifying areas for further investigation.” nature.com · read source
evidence “Meanwhile, Moderna stock declined 4.6% after the vaccine maker announced plans for a $2 billion sale of convertible bonds.” livemint.com · read source